138
Participants
Start Date
October 31, 2009
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Vectical™ Ointment weekdays and Clobex® Spray weekends regimen
Vectical™ Ointment 3 µg/g, topical, apply twice daily on weekdays (Mon-Fri) and Clobex® Spray 0.05% twice daily on weekends (Sat-Sun) for 28 days
Clobex® Spray morning and Vectical™ Ointment evening regimen
Clobex® Spray 0.05%, topical, apply once each morning and Vectical™ Ointment 3 µg/g, topical, apply once each evening for 28 days
Hudson Dermatology, Evansville
Minnesota Clinical Study Center, Fridley
Baylor Research Institute Dermatology Research, Dallas
Dermatology Research Associates, Los Angeles
Therapeutics Clinical Research, San Diego
Probity Medical Research, Waterloo
Lead Sponsor
Galderma R&D
INDUSTRY